Diffusion kurtosis imaging‐derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings
Background Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. Purpose To eval...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 50; no. 3; pp. 930 - 939 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.09.2019
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1053-1807 1522-2586 1522-2586 |
DOI | 10.1002/jmri.26653 |
Cover
Abstract | Background
Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.
Purpose
To evaluate the potential role of diffusion kurtosis imaging (DKI)‐derived parameters using histogram analysis derived from whole‐tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.
Study Type
Retrospective.
Subjects
In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.
Sequence
DKI was performed with a 3.0 T MRI system using a single‐shot echo‐planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2.
Assessment
D, K, and apparent diffusion coefficient (ADC) values were measured using whole‐tumor volume histogram analysis and were compared between different KRAS mutations status.
Statistical Tests
Student's t‐test or Mann–Whitney U‐test, and receiver operating characteristic (ROC) curves were used for statistical analysis.
Results
All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K‐related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.
Data Conclusion
DKI metrics with whole‐tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.
Level of Evidence: 3
Technical Efficacy: Stage 2
J. Magn. Reson. Imaging 2019;50:930–939. |
---|---|
AbstractList | BackgroundAlthough histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.PurposeTo evaluate the potential role of diffusion kurtosis imaging (DKI)‐derived parameters using histogram analysis derived from whole‐tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.Study TypeRetrospective.SubjectsIn all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.SequenceDKI was performed with a 3.0 T MRI system using a single‐shot echo‐planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2.AssessmentD, K, and apparent diffusion coefficient (ADC) values were measured using whole‐tumor volume histogram analysis and were compared between different KRAS mutations status.Statistical TestsStudent's t‐test or Mann–Whitney U‐test, and receiver operating characteristic (ROC) curves were used for statistical analysis.ResultsAll the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K‐related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.Data ConclusionDKI metrics with whole‐tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.Level of Evidence: 3Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2019;50:930–939. Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.BACKGROUNDAlthough histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.To evaluate the potential role of diffusion kurtosis imaging (DKI)-derived parameters using histogram analysis derived from whole-tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.PURPOSETo evaluate the potential role of diffusion kurtosis imaging (DKI)-derived parameters using histogram analysis derived from whole-tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.Retrospective.STUDY TYPERetrospective.In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.SUBJECTSIn all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.DKI was performed with a 3.0 T MRI system using a single-shot echo-planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2 .SEQUENCEDKI was performed with a 3.0 T MRI system using a single-shot echo-planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2 .D, K, and apparent diffusion coefficient (ADC) values were measured using whole-tumor volume histogram analysis and were compared between different KRAS mutations status.ASSESSMENTD, K, and apparent diffusion coefficient (ADC) values were measured using whole-tumor volume histogram analysis and were compared between different KRAS mutations status.Student's t-test or Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were used for statistical analysis.STATISTICAL TESTSStudent's t-test or Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were used for statistical analysis.All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K-related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.RESULTSAll the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K-related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.DKI metrics with whole-tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.DATA CONCLUSIONDKI metrics with whole-tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930-939.LEVEL OF EVIDENCE3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930-939. Background Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. Purpose To evaluate the potential role of diffusion kurtosis imaging (DKI)‐derived parameters using histogram analysis derived from whole‐tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma. Study Type Retrospective. Subjects In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution. Sequence DKI was performed with a 3.0 T MRI system using a single‐shot echo‐planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2. Assessment D, K, and apparent diffusion coefficient (ADC) values were measured using whole‐tumor volume histogram analysis and were compared between different KRAS mutations status. Statistical Tests Student's t‐test or Mann–Whitney U‐test, and receiver operating characteristic (ROC) curves were used for statistical analysis. Results All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K‐related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively. Data Conclusion DKI metrics with whole‐tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy. Level of Evidence: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930–939. Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. To evaluate the potential role of diffusion kurtosis imaging (DKI)-derived parameters using histogram analysis derived from whole-tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma. Retrospective. In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution. DKI was performed with a 3.0 T MRI system using a single-shot echo-planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm . D, K, and apparent diffusion coefficient (ADC) values were measured using whole-tumor volume histogram analysis and were compared between different KRAS mutations status. Student's t-test or Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were used for statistical analysis. All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K-related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively. DKI metrics with whole-tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy. 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930-939. |
Author | Zhuo, Zhizheng Cui, Yanfen Du, Xiaosong Xin, Lei Cheng, Xintao Cui, Xue'e Yang, Zhao Yang, Xiaotang |
Author_xml | – sequence: 1 givenname: Yanfen surname: Cui fullname: Cui, Yanfen organization: Shanxi Province Cancer Hospital, Shanxi Medical University – sequence: 2 givenname: Xue'e surname: Cui fullname: Cui, Xue'e organization: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine – sequence: 3 givenname: Xiaotang orcidid: 0000-0002-2233-1404 surname: Yang fullname: Yang, Xiaotang email: yangxt210@126.com organization: Shanxi Province Cancer Hospital, Shanxi Medical University – sequence: 4 givenname: Zhizheng surname: Zhuo fullname: Zhuo, Zhizheng organization: Philips Healthcare Greater China – sequence: 5 givenname: Xiaosong surname: Du fullname: Du, Xiaosong organization: Shanxi Province Cancer Hospital, Shanxi Medical University – sequence: 6 givenname: Lei surname: Xin fullname: Xin, Lei organization: Shanxi Province Cancer Hospital, Shanxi Medical University – sequence: 7 givenname: Zhao surname: Yang fullname: Yang, Zhao organization: Shanxi Province Cancer Hospital, Shanxi Medical University – sequence: 8 givenname: Xintao surname: Cheng fullname: Cheng, Xintao organization: Shanxi Province Cancer Hospital, Shanxi Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30637861$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1DAUhS1URH9gwwMgS2wQUoodx06GXVWgFIpABdaW41wPd0jsqZ2AZseme56xT1JP024qxMqW9Z1zr8_ZJzs-eCDkKWeHnLHy1WqIeFgqJcUDssdlWRalbNROvjMpCt6wepfsp7RijC0WlXxEdgVTom4U3yOXb9C5KWHw9OcUx5AwURzMEv3y6s_fDiL-go7-wDSGZTQDHWCMaBN1IdJ1hA7tuNUGRz-eH32lwzSamwf0NIIdTU9NBz5YEy36MJjX9EuEHgf0Jm6oQ9_lSekxeehMn-DJ7XlAvr97--34fXH2-eT0-OissELWomgr1grBWM1kK-tF5cqyrqBi0lW1lflzgjvXMiOdAZAZapTksoZOtq0SlRAH5MXsu47hYoI06gGThb43HsKUdMnrhVBl1fCMPr-HrsIUfd5O56kZFIptDZ_dUlM7QKfXMYcXN_ou4AywGbAxpBTBaYtzRGM02GvO9LZDve1Q33SYJS_vSe5c_wnzGf6NPWz-Q-oPn85PZ801i3mueQ |
CitedBy_id | crossref_primary_10_1002_mp_15361 crossref_primary_10_1007_s00261_022_03782_0 crossref_primary_10_1016_j_artmed_2024_102931 crossref_primary_10_1016_j_ejrad_2021_109869 crossref_primary_10_1016_j_cmpb_2021_106311 crossref_primary_10_1159_000515631 crossref_primary_10_1002_jmri_28237 crossref_primary_10_1007_s12029_022_00909_w crossref_primary_10_1016_j_ejrad_2021_109963 crossref_primary_10_4143_crt_2019_050 crossref_primary_10_1007_s00261_019_02073_5 crossref_primary_10_1016_j_patol_2020_07_004 crossref_primary_10_3390_cancers13050973 crossref_primary_10_1186_s43055_020_00393_x crossref_primary_10_1016_j_crad_2021_06_005 crossref_primary_10_1007_s00330_019_06572_3 crossref_primary_10_1007_s10489_020_01658_8 crossref_primary_10_1016_j_crad_2020_06_023 crossref_primary_10_1016_j_ejrad_2022_110245 crossref_primary_10_1007_s00261_024_04523_1 crossref_primary_10_1007_s12094_020_02357_z crossref_primary_10_1007_s00261_021_03369_1 crossref_primary_10_1016_j_compbiomed_2024_108293 crossref_primary_10_1016_j_acra_2021_11_024 |
Cites_doi | 10.1007/s00330-018-5495-y 10.3174/ajnr.A5794 10.1097/RLU.0000000000000481 10.1016/j.ejca.2015.04.007 10.1002/mrm.20508 10.1200/JCO.2015.63.9674 10.1097/DCR.0b013e31821d37a3 10.1093/annonc/mdu378 10.1136/gutjnl-2015-310912 10.2967/jnumed.113.120485 10.1002/jmri.25137 10.3174/ajnr.A5516 10.1016/j.urolonc.2015.05.005 10.1245/s10434-010-0985-4 10.1148/radiol.2017170515 10.1259/bjr.20160212 10.1016/S1470-2045(11)70097-3 10.1158/1078-0432.CCR-09-2446 10.21873/anticanres.11039 10.2307/2531595 10.1158/1078-0432.CCR-11-1909 10.1007/s00330-017-5094-3 10.1002/jmri.25696 10.1016/j.amjsurg.2010.08.016 10.1200/JCO.2007.12.5906 10.1002/jmri.25572 10.1016/S0140-6736(05)17706-X 10.1007/s00330-018-5329-y 10.1158/1078-0432.CCR-15-0526 10.1007/s00330-016-4529-6 |
ContentType | Journal Article |
Copyright | 2019 International Society for Magnetic Resonance in Medicine 2019 International Society for Magnetic Resonance in Medicine. |
Copyright_xml | – notice: 2019 International Society for Magnetic Resonance in Medicine – notice: 2019 International Society for Magnetic Resonance in Medicine. |
DBID | AAYXX CITATION NPM 7QO 7TK 8FD FR3 K9. P64 7X8 |
DOI | 10.1002/jmri.26653 |
DatabaseName | CrossRef PubMed Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-2586 |
EndPage | 939 |
ExternalDocumentID | 30637861 10_1002_jmri_26653 JMRI26653 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Applied Basic Research Programs of Shanxi Province funderid: 201801D121307; 201801D221390 – fundername: the Science and Technology Project of Shanxi Province funderid: 20150313007‐5 |
GroupedDBID | --- -DZ .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HDBZQ HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V8K V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7QO 7TK 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 K9. P64 7X8 |
ID | FETCH-LOGICAL-c3573-b40b3300705b5794f2274e405f47c509931ffb0a5faee505b865157ed5bb63433 |
IEDL.DBID | DR2 |
ISSN | 1053-1807 1522-2586 |
IngestDate | Fri Jul 11 11:17:10 EDT 2025 Fri Jul 25 12:23:07 EDT 2025 Thu Apr 03 06:58:00 EDT 2025 Thu Apr 24 22:52:27 EDT 2025 Tue Jul 01 03:56:41 EDT 2025 Wed Jan 22 16:39:15 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | histogram diffusion kurtosis imaging mutations rectal cancer |
Language | English |
License | 2019 International Society for Magnetic Resonance in Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3573-b40b3300705b5794f2274e405f47c509931ffb0a5faee505b865157ed5bb63433 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2233-1404 |
PMID | 30637861 |
PQID | 2272173603 |
PQPubID | 1006400 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2179362481 proquest_journals_2272173603 pubmed_primary_30637861 crossref_citationtrail_10_1002_jmri_26653 crossref_primary_10_1002_jmri_26653 wiley_primary_10_1002_jmri_26653_JMRI26653 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2019 2019-09-00 20190901 |
PublicationDateYYYYMMDD | 2019-09-01 |
PublicationDate_xml | – month: 09 year: 2019 text: September 2019 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Nashville |
PublicationSubtitle | JMRI |
PublicationTitle | Journal of magnetic resonance imaging |
PublicationTitleAlternate | J Magn Reson Imaging |
PublicationYear | 2019 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2018; 28 2018; 286 2010; 16 2015; 51 2017; 27 2010; 17 2017; 66 2017; 46 2015; 33 2011; 54 2012; 18 2011; 12 2016; 36 2016; 34 2011; 202 2015; 26 2018; 39 2005; 365 2015; 21 2008; 26 1988; 44 2018 2005; 53 2016 2014; 39 2014; 34 2014; 55 2016; 89 2016; 44 Suh CH (e_1_2_6_20_1) 2018 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_21_1 Zhu L (e_1_2_6_25_1) 2016 e_1_2_6_9_1 e_1_2_6_8_1 Krikelis D (e_1_2_6_16_1) 2014; 34 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 12 start-page: 575 year: 2011 end-page: 582 article-title: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12‐year follow‐up of the multicentre, randomised controlled TME trial publication-title: Lancet Oncol – volume: 89 start-page: 20160212 year: 2016 article-title: (18)F‐FDG PET/CT imaging in rectal cancer: Relationship with the RAS mutational status publication-title: Br J Radiol – volume: 33 start-page: 337 e315 year: 2015 end-page: 324 article-title: Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer publication-title: Urol Oncol – volume: 53 start-page: 1432 year: 2005 end-page: 1440 article-title: Diffusional kurtosis imaging: The quantification of non‐Gaussian water diffusion by means of magnetic resonance imaging publication-title: Magn Reson Med – volume: 286 start-page: 571 year: 2018 end-page: 580 article-title: Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging publication-title: Radiology – year: 2018 article-title: Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: A systemic review and meta‐analysis publication-title: Eur Radiol – volume: 46 start-page: 281 year: 2017 end-page: 289 article-title: Lung adenocarcinoma: Assessment of epidermal growth factor receptor mutation status based on extended models of diffusion‐weighted image publication-title: J Magn Reson Imaging – volume: 46 start-page: 1499 year: 2017 end-page: 1506 article-title: Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki‐67 expression publication-title: J Magn Reson Imaging – start-page: 160094 year: 2016 article-title: Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: Preliminary findings publication-title: Radiology – volume: 21 start-page: 5469 year: 2015 end-page: 5479 article-title: Analysis of KRAS/NRAS mutations in a Phase III study of panitumumab with FOLFIRI compared with FOLFIRI alone as second‐line treatment for metastatic colorectal cancer publication-title: Clin Cancer Res – year: 2018 article-title: Predicting genotype and survival in glioma using standard clinical MR imaging apparent diffusion coefficient images: A pilot study from the Cancer Genome Atlas publication-title: AJNR Am J Neuroradiol – volume: 16 start-page: 790 year: 2010 end-page: 799 article-title: Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases publication-title: Clin Cancer Res – volume: 365 start-page: 153 year: 2005 end-page: 165 article-title: Colorectal cancer publication-title: Lancet – volume: 39 start-page: 273 year: 2018 end-page: 279 article-title: Diffusion‐weighted imaging of brain metastasis from lung cancer: Correlation of MRI parameters with the histologic type and gene mutation status publication-title: AJNR Am J Neuroradiol – volume: 36 start-page: 4799 year: 2016 end-page: 4804 article-title: Prediction of KRAS mutation in rectal cancer using MRI publication-title: Anticancer Res – volume: 39 start-page: 685 year: 2014 end-page: 689 article-title: Correlation between PET/CT parameters and KRAS expression in colorectal cancer publication-title: Clin Nucl Med – volume: 28 start-page: 3059 year: 2018 end-page: 3065 article-title: Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer? publication-title: Eur Radiol – volume: 34 start-page: 179 year: 2016 end-page: 185 article-title: Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti‐epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 publication-title: J Clin Oncol – volume: 44 start-page: 221 year: 2016 end-page: 229 article-title: Correlation of standard diffusion‐weighted imaging and diffusion kurtosis imaging with distant metastases of rectal carcinoma publication-title: J Magn Reson Imaging – volume: 66 start-page: 683 year: 2017 end-page: 691 article-title: Global patterns and trends in colorectal cancer incidence and mortality publication-title: Gut – volume: 26 start-page: 374 year: 2008 end-page: 379 article-title: KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab publication-title: J Clin Oncol – volume: 27 start-page: 1848 year: 2017 end-page: 1857 article-title: The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer publication-title: Eur Radiol – volume: 28 start-page: 1485 year: 2018 end-page: 1494 article-title: Whole‐tumour diffusion kurtosis MR imaging histogram analysis of rectal adenocarcinoma: Correlation with clinical pathologic prognostic factors publication-title: Eur Radiol – volume: 44 start-page: 837 year: 1988 end-page: 845 article-title: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach publication-title: Biometrics – volume: 54 start-page: 1170 year: 2011 end-page: 1178 article-title: Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer publication-title: Dis Colon Rectum – volume: 34 start-page: 2571 year: 2014 end-page: 2579 article-title: Lack of association between KRAS mutations and 18F‐FDG PET/CT in Caucasian metastatic colorectal cancer patients publication-title: Anticancer Res – volume: 18 start-page: 1696 year: 2012 end-page: 1703 article-title: Relationship between 18F‐fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer publication-title: Clin Cancer Res – volume: 55 start-page: 386 year: 2014 end-page: 391 article-title: Multifunctional imaging signature for V‐KI‐RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer publication-title: J Nucl Med – volume: 51 start-page: 1243 year: 2015 end-page: 1252 article-title: FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer publication-title: Eur J Cancer – volume: 26 start-page: 13 year: 2015 end-page: 21 article-title: Extended RAS mutations and anti‐EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: A meta‐analysis of randomized, controlled trials publication-title: Ann Oncol – volume: 17 start-page: 1471 year: 2010 end-page: 1474 article-title: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann Surg Oncol – volume: 202 start-page: 419 year: 2011 end-page: 426 article-title: Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma publication-title: Am J Surg – year: 2018 article-title: Diffusion kurtosis imaging in the characterisation of rectal cancer: Utilizing the most repeatable region‐of‐interest strategy for diffusion parameters on a 3T scanner publication-title: Eur Radiol – ident: e_1_2_6_27_1 doi: 10.1007/s00330-018-5495-y – ident: e_1_2_6_21_1 doi: 10.3174/ajnr.A5794 – ident: e_1_2_6_15_1 doi: 10.1097/RLU.0000000000000481 – ident: e_1_2_6_9_1 doi: 10.1016/j.ejca.2015.04.007 – ident: e_1_2_6_22_1 doi: 10.1002/mrm.20508 – ident: e_1_2_6_10_1 doi: 10.1200/JCO.2015.63.9674 – ident: e_1_2_6_11_1 doi: 10.1097/DCR.0b013e31821d37a3 – ident: e_1_2_6_7_1 doi: 10.1093/annonc/mdu378 – ident: e_1_2_6_5_1 doi: 10.1136/gutjnl-2015-310912 – ident: e_1_2_6_14_1 doi: 10.2967/jnumed.113.120485 – ident: e_1_2_6_24_1 doi: 10.1002/jmri.25137 – start-page: 160094 year: 2016 ident: e_1_2_6_25_1 article-title: Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: Preliminary findings publication-title: Radiology – ident: e_1_2_6_19_1 doi: 10.3174/ajnr.A5516 – ident: e_1_2_6_32_1 doi: 10.1016/j.urolonc.2015.05.005 – year: 2018 ident: e_1_2_6_20_1 article-title: Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: A systemic review and meta‐analysis publication-title: Eur Radiol – ident: e_1_2_6_28_1 doi: 10.1245/s10434-010-0985-4 – ident: e_1_2_6_31_1 doi: 10.1148/radiol.2017170515 – ident: e_1_2_6_17_1 doi: 10.1259/bjr.20160212 – ident: e_1_2_6_3_1 doi: 10.1016/S1470-2045(11)70097-3 – ident: e_1_2_6_12_1 doi: 10.1158/1078-0432.CCR-09-2446 – ident: e_1_2_6_18_1 doi: 10.21873/anticanres.11039 – ident: e_1_2_6_29_1 doi: 10.2307/2531595 – ident: e_1_2_6_13_1 doi: 10.1158/1078-0432.CCR-11-1909 – ident: e_1_2_6_26_1 doi: 10.1007/s00330-017-5094-3 – ident: e_1_2_6_30_1 doi: 10.1002/jmri.25696 – ident: e_1_2_6_4_1 doi: 10.1016/j.amjsurg.2010.08.016 – ident: e_1_2_6_6_1 doi: 10.1200/JCO.2007.12.5906 – volume: 34 start-page: 2571 year: 2014 ident: e_1_2_6_16_1 article-title: Lack of association between KRAS mutations and 18F‐FDG PET/CT in Caucasian metastatic colorectal cancer patients publication-title: Anticancer Res – ident: e_1_2_6_33_1 doi: 10.1002/jmri.25572 – ident: e_1_2_6_2_1 doi: 10.1016/S0140-6736(05)17706-X – ident: e_1_2_6_34_1 doi: 10.1007/s00330-018-5329-y – ident: e_1_2_6_8_1 doi: 10.1158/1078-0432.CCR-15-0526 – ident: e_1_2_6_23_1 doi: 10.1007/s00330-016-4529-6 |
SSID | ssj0009945 |
Score | 2.4310129 |
Snippet | Background
Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display... Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the... BackgroundAlthough histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 930 |
SubjectTerms | Adenocarcinoma Colorectal cancer Diagnostic systems Diffusion Diffusion coefficient diffusion kurtosis imaging Genotypes Heterogeneity histogram Histograms K-Ras protein Kurtosis Magnetic resonance imaging Medical imaging Mutation mutations Predictions rectal cancer Rectum Statistical analysis Statistical tests Tumors |
Title | Diffusion kurtosis imaging‐derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.26653 https://www.ncbi.nlm.nih.gov/pubmed/30637861 https://www.proquest.com/docview/2272173603 https://www.proquest.com/docview/2179362481 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFLYQB8QFylamBWQEl1bKMLHjLIgLYhGLpqoGkLigKM7YVUqToGTSQ09cuPMb-0v6npPJiEWV4BbJThzbb_nsZ3-PkG2hbU_5GNUFvGABIrYtyVWMNK7g0EDFhIme97-5J1fO2bW4niJ747swNT9Eu-GGmmHsNSp4JMudCWnoz7RIuuBeBFJ92txF4vzDwYQ7KghMhmLAD9yy_Z7XcpOyncmrT73RC4j5FLEal3M8T27GP1ufNLntViPZjf8843F8b28-kLkGi9L9WngWyJTKFslMv4m2L5GHw0TrCrfT6G1VjPIyKWmSmrRGf-8fhyC7v9WQGsZiPONFU8zOFZcUcDC9K_AzOOs01_R8sH9B06oO-9Mko2hnoekIrB440wLay9Nol34voBupuSJMTTQ9-1Euk6vjo8uDE6tJ22DFXHjckk5Pco48QkIKUHfNYOWrABhqx4sBnwTc1lr2IqEjpQCASR_TsXtqKKR0ucP5CpnO8kytEuo5jpKBGEoGXjRiLGCu1gAyfRnEjHt2h3wZT18YN5zmmFrjV1izMbMQxzU049ohW23du5rJ49Vaa2MpCBttLkPoAKzcuNuD4s22GPQQgytRpvIK6qClc5njw099rKWnbQaWZdzzXSj5amTgP-2HZ_3BqXn69JbKn8ksILnm8NsamR4VlVoHtDSSG0Yr_gElBhED |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYKlUovPAoUChRX7aVIWTZ2nEdvq7ZoeSyqtiBxi-KsjQIkQcmmh5564c5v5Jcw42SzokVI9BbJThzbM57PnvE3hHwS2vaUj15dwAsWIGLbklzFSOMKBg1UTBjv-eDY7Z86B2firInNwbswNT9Ee-CGmmHWa1RwPJDenbKGXqRF0gH7IvgMeWkcdIiJhlP2qCAwOYoBQXDL9rtey07KdqfvPrRH_4DMh5jVGJ29hTqzamm4CjHW5LJTjWUn_v0Xk-N_92eRzDdwlPZq-VkiL1T2hrwaNA73ZXLzLdG6whM1elkV47xMSpqkJrPR3Z_bEYjvLzWihrQYw7xoigm64pICFKbXBX4GJ57mmh4Oez9pWtWef5pkFJdaaDqChQ_saQHt5Wn0hf4ooB-puSVMjUM9Oy9XyOne95OvfavJ3GDFXHjckk5Xco5UQkIK0HjNYPOrABtqx4sBogTc1lp2I6EjpQCDSR8zsntqJKR0ucP5KpnN8kytEeo5jpKBGEkGhjRiLGCu1oAzfRnEjHv2Ovk8mb8wbmjNMbvGVVgTMrMQxzU047pOPrZ1r2syj0drbU7EIGwUugyhA7B5424Xij-0xaCK6F-JMpVXUAcXO5c5PvzU21p82mZgZ8Y934WSHSMET7QfHgyG--bp3XMqb5O5_sngKDzaPz7cIK8B2DWxcJtkdlxUagvA01i-NypyDyVLFSE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8KBYzgAlK2GzvOA3GpKKs-2KpaqNRLFcWJjUJJsko2HDhx4c5v5Jcw42SzKiAkuEWyE8f2PD577G8AnknjBjqkqC7iBQcRsesooVOicUWHhiombfR8euTvnXgHp_J0DV4t78J0_BDDhhtphrXXpODzzGyvSEM_FnU-QvcixSW47PnoJwkSzVbkUVFkUxQjgBCOG46DgZyUb6_eveiOfsOYFyGr9TmTa3C2_NvuqMn5qF2oUfrlFyLH_-3Odbjag1G200nPDVjT5U3YmPbh9lvwbTc3pqX9NHbe1ouqyRuWFzav0Y-v3zMU3s86Y5aymA55sYLSc6UNQyDM5jV9hqadVYYdznbesaLt4v4sLxkZWmw6QbOH3rTG9qoiecmOa-xGYe8IMxtOLz80t-Fk8ub96z2nz9vgpEIGwlHeWAlBREJSSdR3w3HpqxEZGi9IEaBEwjVGjRNpEq0RgamQ8rEHOpNK-cIT4g6sl1Wp7wELPE-rSGaKoxtNOI-4bwyizFBFKReBuwnPl9MXpz2pOeXW-BR3dMw8pnGN7bhuwtOh7ryj8vhjra2lFMS9OjcxdgCXbsIfY_GToRgVkaIrSamrFuuQqfO5F-JP3e2kZ2gG12UiCH0seWFl4C_txwfT2b59uv8vlR_DxvHuJH67f3T4AK4gqusPwm3B-qJu9UNETgv1yCrIT942E9A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diffusion+kurtosis+imaging-derived+histogram+metrics+for+prediction+of+KRAS+mutation+in+rectal+adenocarcinoma%3A+Preliminary+findings&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Cui%2C+Yanfen&rft.au=Cui%2C+Xue%27e&rft.au=Yang%2C+Xiaotang&rft.au=Zhuo%2C+Zhizheng&rft.date=2019-09-01&rft.eissn=1522-2586&rft.volume=50&rft.issue=3&rft.spage=930&rft_id=info:doi/10.1002%2Fjmri.26653&rft_id=info%3Apmid%2F30637861&rft.externalDocID=30637861 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon |